Background. The number of migrants and refugees in Europe in the past few years has increased dramatically due to war, violence or prosecutions in their homeland. Migration may affect physical, mental and social health. The objective of this article is to assess migrants and refugees' health problems, and to recommend appropriate interventions. Methods. A PubMed search of published articles on health problems of newly arrived migrants and refugees was conducted from 2003 through 2016, focusing on the current refugee crisis in Europe.
Introduction
Globalization, demographic and societal changes are affecting the countries of European Union (EU) and around the world. In 2015, the number of international migrants worldwide reached 244 million, which represents 3% of the world population, the highest ever recorded. 1 A total of 3.8 million people immigrated to one of the EU-28 Member States during 2014 alone, including 1.9 million immigrants from non-member countries. 2 Female migrants constitute 52.4% of migrant population in Europe. 2 During 2015 over 65 million people were displaced with more than half originating from three war-torn countries, in particular Syria, Afghanistan and Somalia, which represents the highest forced displacement globally since World War II.
communication between health care practitioners and migrant people remains poor. In addition, there is often inadequate responsiveness of health care systems due to poor preparedness which is enhanced by legal issues that migrants have to face with in relation to health and other basic services. 6 Approaches to manage migration health problems have not kept pace with increasing challenges associated with the size, speed, diversity and disparity of current migration patterns and factors such as barriers to access health services have not sufficiently been addressed. 7 Although a few publications on migrant and refugee health have appeared in recent years, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] comprehensive information on different aspects of health and migration, and how these can appropriately be addressed by the health systems of European countries, is still not easy to define. The objective of this article is to review available data about health problems of migrants and refugees during their immigration and in particular at arrival and during their early settlement at temporary camps. Appropriate interventions for their management are also discussed.
Review Strategy
A PubMed search was conducted from 2003 to February 2016 using combinations of the following keywords: refugees, migrants, Europe, health problems and health care access. English and Italian language articles presenting original data on health problems of newly arrived migrants and refugees were selected for review. Only articles providing data about the communicable and non-communicable disease (NCDs) cases in migrant and refugees on arrival and during their settlement at points of care (PoCs) were included in the analysis, as well as data about their health care access in host countries. In addition, data from review articles referring to migrant and refugees' health problems and from relevant national and international websites were used, such as the World Health Organization (WHO), EUROSTAT, UNHCR, European Center for Disease Control and Prevention (ECDC) and Hellenic Centre for Disease Control and Prevention (HCDCP). Migrant is described according to the UNHCR, as someone who makes a conscious, voluntary choice to leave his/her country of origin and who, voluntarily, can return home in safety. Refugee is defined as the person who does not have this option and is formally owed protection, including access to health services, from the first country of registration of asylum, 22 where the asylum claim has been accepted. Asylum seeker is the person whose claim for refuge is under consideration. 23 Undocumented migrants are defined as those who do not possess legal documents for residency and may be forced migrants who are unable to claim asylum and, therefore, have no access to health care.
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Health Problems of Migrating Persons
The duration of migration status process and living in detention centres can have a significant impact upon migrant health. 24 All phases of the immigration process including the period while on 'the move' and the time of arrival and later, the period of living in the host country may affect communicable and NCDs in migrants.
Health Problems During Travel and Arrival
Refugees are particularly vulnerable to contagious infectious diseases during their travel because of the destroyed health care systems, including vaccination services in their countries of origin, and public health infrastructures (e.g. potable water network and housing), overcrowded conditions with sub-optimal hygiene standards during travel, malnutrition and lack of access to health care services. On arrival, the most common health problems in migrants and refugees recorded at the PoCs may be related to problems in their country of origin (e.g. political crisis, war) and the journey including accidental injuries, hypothermia, gynaecological and obstetric complications, gastrointestinal and respiratory illnesses, dermatological, cardiovascular events, mental illness and metabolic problems (Table  1) . 10, 15 In particular, unaccompanied minors, female and children migrants and refugees are vulnerable for specific problems in relation to maternal, newborn and child health, gynaecological issues and violence. 25 Although women and young people among migrants and refugees are vulnerable to sexual and gender-based violence (SGBV) worldwide, little evidence exists concerning SGBV against refugees in Europe. 26 In addition, drug and alcohol abuse, nutrition problems and exposure to violence may increase refugees' vulnerability to NCDs. 24 Furthermore, prior to migration, access to health care services may have been restricted or unavailable, which makes several health conditions less effectively managed in migrating people. 27 Mental and psychosocial illness is a significant health problem for migrants and refugees, in particular newly arrived people, including depression, anxiety disorder, alcoholism and drug abuse as a result of traumatic experiences prior to dislocation or during the migration process which may be related to war, hunger, physical and sexual abuse. 27 Language difficulties, cultural and religious issues, racism and unemployment may further aggravate mental problems. Risk factors for mental illness in migrants and refugees include also age, gender, lower socioeconomic status and lack of social support. [28] [29] [30] Older people are more vulnerable. Women are also more vulnerable due to the increased risk of sexual abuse and pregnancy (poor access to oral contraception). 26 Vulnerable groups, such as children, are prone to respiratory and gastrointestinal infections and dermatologic conditions (e.g. scabies) due to sub-optimal hygienic and inadequate living conditions, and nutritional deprivation during migration. Genderspecific problems, such as maternal, reproductive and access to contraception and family planning also constitute important challenges for migrants. Therefore, access to reproductive health services, prenatal and obstetric care and preventive health care (e.g. screening) is crucial. 26 
Health Problems During Early Settlement at PoCs
After the initial phase, migrants and refugees are usually hosted in reception centres before reaching their final destination. By definition, they originate from countries affected by war or economic crisis and undertake long, exhausting journeys to be accommodated in overcrowded reception centres or camps under poor hygienic conditions; these factors increase their risks for communicable diseases. 13, 15, [31] [32] [33] [34] Communicable diseases are associated with war, poverty, population movement, overcrowded conditions, poor hygiene and malnutrition; in particular immunocompromised or elderly people under such conditions are at higher risk for acquiring infectious diseases. 35 Although the likelihood that certain infectious diseases will occur among migrants is low, they should still be considered, to ensure that they are diagnosed and treated in a timely manner, or prevented by vaccination when indicated, in order to control the risk of disease spread. There is a need for more studies for disease-specific risk assessment in migrants in the European Union and the European Economic Area (EU/EEA). 36 The country of origin and the local epidemiology is an important factor when considering infectious diseases in newly arrived migrants and refugees. The five most common countries of origin of migrants and refugees coming to Europe currently include Syria, Afghanistan, Iraq, Eritrea and Somalia. Hepatitis A is highly endemic in all five countries and also there is a risk for typhoid fever. 36, 37 There are recurrent cholera outbreaks in
Afghanistan and Somalia and an ongoing outbreak in Iraq; 38 however, due to short incubation time the risk for cholera transmission is low. The incidence of tuberculosis (TB) in the above countries varies from as low as 17 new cases per 100 000 population in the Syrian Arab Republic to 189, 285 and 499 per 100 000 population in Afghanistan, Somalia and Eritrea, respectively. 39 The average TB rate in the European Region is 39
per 100 000 population. 36 The risk of migrants and refugees for acquiring TB or being infected, depends on factors such as the incidence of the disease in their country of origin, their living and working conditions in the country of immigration, access to health care services and welfare, history of close contact with an active case and the conditions of transport during their journey to Europe (e.g. poorly ventilated accommodation). 39 A recent systemic review of 51 studies on crisis-affected populations showed a 20-fold increase of TB cases among them, while notifications were highly affected. 39 Destroyed health care systems, discontinuation of previous anti-TB treatment, HIV-coinfection, discontinuation of anti-retroviral treatment, malnutrition, physical and psychological stress, may all have an impact on TB incidence, leading to an increase of active, contagious cases including cases of multi-drug resistant TB. 40 However, there is substantial absence of risk of infection on the local TB epidemiology. 41 HIV prevalence in the five most common countries of origin of migrants and refugees is low and therefore the risk of HIV importation to Europe by migrants is low; 25, 36 however, migrants still constitute 35% of new HIV cases in the EU/ EEA and there is increasing evidence that some migrants acquire HIV after their arrival. 25 In 2015, almost 30 000 people were diagnosed in the EU and European Economic Area Member States, which corresponds to a rate of 6.3 cases per 100 000 population. 42 The advancing Migrant Access to health Services in Europe (aMASE) study aims to identify the structural, cultural and financial barriers to HIV prevention, diagnosis and treatment, to determine the likely country of HIV acquisition in HIV-positive migrant populations and also to provide data about post-migration HIV acquisition. 43 A recent Canadian study among newly arrived refugee patients revealed that the overall prevalence rate of HIV infection was 2%. 13 A Greek study which was carried out at Greek-Turkish borders, among migrants and refugees mainly originating from the Indian subcontinent, Somalia, Morocco and Iraq showed that 0.3% of them were tested positive for HIV. 15 Migrants and refugees from East Asia and sub-Saharan Africa have the highest seroprevalence of chronic hepatitis B virus (HBV) infection (10% HBsAg positive) and those from Eastern Europe and Central Asia and South Asia have intermediate seroprevalence (4-6%). 44 Migrants from sub-Saharan Africa, Asia and Eastern Europe and older age groups have the highest risk for hepatitis C virus (HCV) prevalence ranging from 2.2 to 5.6%. 45 A recent Canadian study among newly arrived refugee patients revealed that the prevalence of hepatitis B infection was 4%, with a higher rate among refugees from Asia. 13 A retrospective analysis of HBV screening in travellers revealed that HBV seroprevalence was higher than in European population, due to the large number of individuals with immigrant background. 46 A Greek study, which was carried out among migrants and refugees originating from the Indian subcontinent, Somalia, Morocco and Iraq showed that 3.2 and 0.8% were tested positive for HBV and HCV, respectively; 15 these studies highlight the fact that migrants originating from intermediate or high hepatitis B and C prevalence countries who live in low HBV or HCV prevalence immigrant-receiving countries are an important risk group for chronic HBV and HCV infection. 45, 46 In addition to the country of origin, physical and mental stress and poor living conditions in crowded reception centres and refugee camps are associated with respiratory infections, mainly influenza, respiratory syncytial virus, adenovirus and parainfluenza virus infections. Therefore, WHO supports policies for provision of seasonal influenza vaccine to risk groups, irrespective of their legal status. 25 According to a Greek study, the most common diagnosis in newly arrived migrants at a Greek-Turkish border was respiratory disease (23%) ( Table 1) . 15 Recent data from the syndromic surveillance system at PoC for migrants and refugees which has been carried out at 51 reception centres in Greece, also revealed that the most common infection was respiratory infection with fever (55%). Suspected TB was reported in 0.56% of the cases. 33 TB is not easily transmissible and active disease occurs in only a proportion of those infected and within few months or few years after infection. 41 Sub-optimal living conditions and lack of access to appropriate food and water may also increase the risk of gastrointestinal infections. 14, 36 According to a German study in symptomatic migrant patients, 38% of them carried an infectious disease, mainly nematodes and intestinal protozoa. 8 Italian studies
showed that parasitic disease was the second most common infection diagnosed in symptomatic migrants, 9 and gastrointestinal illness was diagnosed in 10.4% of newly arrived migrants. 10 Gastroenteritis without blood in the stool accounted for 29% of the cases at PoCs in Greece. 33 Meningococcal disease outbreaks have also been reported in overcrowding refugee settings with sub-optimal hygienic conditions, 33, 36 as well as other vaccine preventable diseases such as measles, rubella and varicella. 33, [45] [46] [47] [48] [49] [50] Data from the syndromic surveillance at PoCs in Greece showed that meningitis and/or encephalitis accounted for 0.03% of all cases, 33 and rash with fever and jaundice of acute onset accounted for 6.5% and 0.3%, respectively. 33 Possible diagnoses for the last two syndromes were varicella and hepatitis A, respectively. Although hepatitis A immunity in adult refugees is shown to be high, 32 hepatitis A outbreaks among children may also occur. 33 Migrants to countries with a temperate climate are at risk of acquiring varicella infection during adulthood due to the lower proportion of adults with positive varicella serology in populations from tropical countries. 50 Vector borne diseases such as lice, flea and mite transmitted infections are also common in crowded reception centres and refugee camps with poor hygienic standards. 15, 33, 36 Vector borne dermatological infections such as scabies accounted for 8.5% at PoCs in Greece; 33 immunocompromised or elderly patients may constitute the main source of transmission. 35 In addition, malaria was diagnosed with rapid detection test in 0.02% of all cases reported by the PoC in Greece. 33 The risk for reintroduction of vector-borne diseases such as malaria can be increased by a mass influx of migrants and refugees, as shown by the recent resurgence of malaria in Greece which was directly related to an influx of migrants from Pakistan. 25, 51 This experience emphasizes the ongoing threat of reintroduction and the need for continued vigilance to ensure that any resurgence can be rapidly contained since malaria risk is high in countries where many migrants and refugees to Europe originate from reference. 25 Sexually transmitted diseases also constitute an important health problem as shown by the Italian study which revealed that the most frequent diagnoses in migrants in a dayhospital were sexually transmitted diseases. 9 The above data emphasize the importance of screening for infectious diseases among refugee and migrant patients in order to provide timely preventive and curative management. These data may also suggest possible policy and clinical implications, such as targeted screening approaches and access to vaccinations and therapeutics. However, the cost of screening and the appropriate time should be taken under consideration, especially for countries hosting a large number of refugees and migrants.
Migrants and refugees with NCDs may be more vulnerable as a result of the suboptimal conditions during their journey and early settlement in the receiving country before their final destination. Displacement results in interruption of the continuous management that is crucial for chronic conditions. Chronic conditions can acutely exacerbate or cause complications and a lifethreatening deterioration. In particular, elderly people and children are at greater risk. Lack of access or decimation of health care systems and service providers constitute the key issues in relation to NCDs. Common characteristics of NCDs that make migrant and refugees more vulnerable include the need for (i) provision of follow-up over a long time, (ii) regular treatment (e.g. medication), (iii) management of acute complications of chronic diseases, (iv) co-ordination of health care services and follow-up among various providers and institutions and (v) possible palliative care. 25 The epidemiological profile of migrants is different from that of local-born residents. Therefore, the influx of migrants may increase the diversity in the health of European populations, including the pattern of NCDs. 27, 52, 53 Some NCDs occur more often among migrant groups; e.g. diabetes mortality rates in migrants are higher than in the local-born populations, in particular among migrants from North Africa, the Caribbean and South Asia. 6, 14, 19 Migrants and refugees from West Africa have higher incidence of hypertension and cerebrovascular disease, while those originating from Afghanistan, Iraq and Northern Africa have higher rates for coronary heart disease. 14, 17, 54 Increased stroke mortality levels may be partly associated with factors such as difficulty in timely diagnosis and care for patients with hypertension or stroke. Iron deficiency anaemia occurs more often in women and children migrants. 14 Migrants are more prone to cancers that are related to infections experienced in early life, such as liver, cervical and stomach cancer. In contrast, migrants of non-western origin are less likely to suffer from cancers related to a western lifestyle, e.g. colorectal, breast and prostate cancer. 20, 21 Studies focusing on specific diseases often show great diversity between different migrant groups, in particular regarding the relation of the risk with the country of origin. 27 Overall, approximately 51% of refugees report a chronic disease. 12 In addition to communicable diseases and NCDs, population movement across borders has played an important role also in the dissemination of new antimicrobial resistance mechanisms globally. Examples include MDR-Gram negative pathogens (e.g. New-Delhi Metallo-beta-lactamase), MDR and extensively drug resistant TB, resistant Neisseria gonorrhoeae, high-level resistance to penicillin G Streptococcus pneumoniae, MDRplasmodium falciparum and drug-resistant influenza strains; therefore, there is a need for prompt preparation of health care systems at the national and international level for the safety within health care facilities for all patients. 55 
Access to Health Care of Newly Arrived Migrants and Refugees in Europe
Access to health care of newly arrived migrants and refugees is shaped by legal frameworks in regards to migration status of each person. 24 Other barriers in accessing health care services include cultural issues, language difficulties, bureaucratic barriers (e.g. social allowances) and structural problems. According to the 1951 UNCR Convention regarding the Status of Refugees, a refugee has the same right to access the national health services in the country of refuge as the citizens of that country. 56 Health regulations towards refugees vary significantly among the EU countries and may influence a refugee's access to health care services. 57 There are different entitlements to care for different migrant groups; undocumented migrants and unaccompanied minors need special attention. In the majority of EU countries, most undocumented migrants only have access to emergency health care. 58 Screening programs of refugees upon arrival in the EU vary among EU countries and may also be voluntary or involuntary. 55, 59 Access to health care for refugees and asylum seekers is not only a problem of acute provision at initial reception on arrival, but also of ongoing care during longer resettlement for chronic as well as acute health needs. Some health care services are specifically provided in reception centres of refugees and asylum seekers across the EU, however, access may be available from the same health institution as the general population; therefore, adaptation of mainstream provision is crucial. Access to health care across the EU is adjusted to legal frameworks of the migration process and is further influenced by communication, language and financial difficulties and cultural problems. Nongovernmental and humanitarian agencies often support communication and access for refugees and asylum seekers, but their ability to provide ongoing care and to co-ordinate with other organizations is limited. Therefore, there is a need for improvement in communication with asylum seekers and co-ordination between agencies within and beyond the medical system. It is important for WHO European Region and policy-makers to develop specific and coherent policies addressing the health needs of all migrants, including asylum seekers and refugees. 60 
Recommendations for the Management of Newly Arrived Migrants and Refugees Health Issues
Provision of health care at PoC and reception centres of newly arrived migrants and refugees should be person-centred, compassionate, affordable, comprehensive and integrated for all ages and all illnesses. Health care should be provided by a multidisciplinary team and care providers with 'cultural humility' in co-ordination with the local health care system and other organizations. Services should be based on a holistic approach, including health assessment and management of communicable and NCDs, such as chronic diseases, mental and social problems with the provision of ongoing care. Triage which is referred to assessment and prioritization of patients based on acute illness, both physical and mental, is recommended upon arrival at PoC to detect health problems and to provide appropriate health care irrespective of legal status, in particular for vulnerable population groups (unaccompanied minors, children, pregnant women and the elderly). 27 In order to facilitate co-ordination of care provision and follow-up among various providers and settings, the use of portable medical records and personal medical documentation is advisable. Communication services (i.e. cultural mediators, interpreters) for health care providers should be available, or improved, for the promotion of an inclusive and culturally sensitive health system. 24 Measures to reduce the risk of communicable diseases include the implementation of health prevention and management at PoC, such as clinical assessment, access to medical diagnosis and management services (e.g. investigation, treatment and hospitalization), surveillance, vaccination and implementation of appropriate screening. Surveillance will improve the level of information available in regards to the risk assessment on infectious diseases, the facilitation of early detection of epidemicprone diseases to promptly implement prevention and control measures. Syndromic surveillance in reception centres is an important tool and may include infectious diseases such as respiratory infections, TB, diphtheria, gastrointestinal illness, rash with fever, dermatological conditions (scabies), jaundice with acute onset, malaria, neurological manifestations of acute onset, meningitis and/or encephalitis, haemorrhagic manifestations with fever and sepsis or unexplained shock; however, this should complement and not substitute the mandatory notification of infectious diseases in the EU countries. 33, 61 Information on transmission of vaccine-preventable diseases among migrants and refugees is not routinely recorded at the WHO Regional Office for Europe; however, well-documented outbreaks of VPDs such as measles or varicella have been reported among migrants and refugees. 25, 33 Therefore, access to vaccination which is theoretically cost-effective is of prime importance. Vaccinations for migrants and refugees should be considered in accordance with national guidelines. In case of vaccination administration, vaccination records should be provided, in particular when migrants and refugees are moving between countries. According to ECDC and WHO vaccinations for susceptible migrants/refugees may include: (i) measlesmumps-rubella for children 15 years, (ii) poliomyelitis (for children and adults originating from countries exporting poliovirus, e.g. Afghanistan and Pakistan, countries with infection such as Somalia, or countries vulnerable to international spread, e.g. Cameroon, Equatorial Guinea, Ethiopia, Iraq, Israel and the Syrian Arab Republic), (iii) meningococcal disease (tetravalent vaccines against meningococcal serogroups A, C, W-135 and Y or, against serogroups A and/or C), (iv) tetanus-pertussisdiphtheria and (v) influenza, according to the season. 60 According to WHO, screening of migrants and refugees for diseases is not obligatory; however, screening for certain diseases such as latent TB, viral hepatitis and intestinal parasites in high-risk groups has shown to be cost-effective. 62, 63 Screening may cause anxiety in individual migrants and refugees and the local community. The results of screening must never be used as a reason or justification for deporting a refugee or a migrant from a country. Screening of migrants and refugees for certain diseases is part of the prevention and control strategy for some EU countries and it should be considered in accordance with their national guidelines. 64 Selection of specific infectious diseases for screening should be based on the symptoms presented by migrants during clinical examination. In addition, screening is considered for asymptomatic migrants for certain infectious diseases based on the epidemiology of their country of origin. 36, [64] [65] [66] [67] By far, the most common disease screened in EU countries is TB. 64 Other diseases include HIV, hepatitis B, hepatitis C, and to a lesser extend sexually transmitted diseases and VPDs. [64] [65] [66] [67] Recommendations for actions, considering costeffectiveness, should follow screening results, including implementation of early treatment preventing substantial numbers of future cases. 62, 63, 68 However, in regards to certain diseases, including HIV and hepatitis C treatment, due to the variation of access to health care services across Europe, a significant number of EU/EEA countries do not provide antiretroviral treatment to undocumented migrants. 69, 70 Other recommendations in terms of treatment, empiric treatment on certain diseases including malaria, parasitosis and TB is shown by some studies that it may be cost effective and reduce morbidity and the risk of imported infections.
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Conclusions
The migrant and refugee crisis in Europe has reached a critical point. The great majority of migrants and refugees are in a good physical condition; however, many are challenged with medical and mental problems, social isolation and economic devastation. There are different migrant groups with different rights to access of care. Many European countries are experiencing an increased wave of migrants and refugees and should consider therefore assessing their overall preparedness and response capacity for the management of the disease burden in this population which should be based on the actual migration flows, global disease patterns and consequent needs.
Public health interventions in refugee camp settings will not only benefit migrants and refugees at individual level but also assist their integration in to the new home countries. In particular, it is important to consider the economic benefit of early interventions.
Intersectoral and international collaboration is important to meet the heterogeneous needs of these populations which could foster integration. Providing newly arrived migrants and refugees a more systematic health-reception, based on a holistic approach by a multidisciplinary team, will not only benefit migrants and refugees but also will protect the public health of host countries.
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